搜索筛选:
搜索耗时2.2005秒,为你在为你在102,285,761篇论文里面共找到 14 篇相符的论文内容
发布年度:
Cobalt phosphide nanoarrays with crystalline-amorphous hybrid phase for hydrogen production in unive
[期刊论文] 作者：Hyunseok Yoon,Hee Jo Song,Bobae Ju,Dong-Wan Kim,
来源：纳米研究（英文版） 年份：2020
To accomplish mass hydrogen production by electrochemical water-splitting,it is a necessary to develop robust,highly active,stable,and cost-effective hydrogen e...
Comparison of toxicity between iron oxide nanoparticles with different properties on ten different c
[会议论文] 作者：Eun-Jung Park,Donghyeuk Choi,Jae-Ho Kim,Sang-Wook Kim,Younghun Kim,Dong-Wan Kim,
来源：The 6 th International Conference on Nanotoxicology (第六届国际纳米 年份：2012
...
Comparison of toxicity between iron oxide nanoparticles with different properties on ten different c
[会议论文] 作者：Eun-Jung Park,Donghyeuk Choi,Younghun Kim,Dong-Wan Kim,Jae-Ho Kim,Sang-Wook Kim,
来源：The 6 th International Conference on Nanotoxicology (第六届国际纳米 年份：2012
...
In vitro analysis of toxicity by different types of TiO2 nanorods and nanowires on various cell line
[会议论文] 作者：Eun-Jung Park,Hyun-Woo Shim,Gwang-Hee Lee,Younghun Kim,Sang-Wook Kim,Jae-Ho Kim,Dong-Wan Kim,
来源：The 6 th International Conference on Nanotoxicology (第六届国际纳米 年份：2012
...
[会议论文] 作者：Eun-Jung Park,Nur Elida M.Zahari,SeungYun Lee,Younghun Kim,Dong-Wan Kim,Sang-Wook Kim,Jae-Ho Kim,
来源：The 6 th International Conference on Nanotoxicology (第六届国际纳米 年份：2012
...
Activity of the c-Met inhibitor tepotinib (MSC2156119J) in combination with gefitinib in Asian patie
[会议论文] 作者：Yi-long Wu,Keunchil Park,Dong-wan Kim,Ross a.Soo,Huiling Xiong,Cindy Li,Christian Ihling,James chih-hsin,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: c-Met abnormalities can cause resistance to EGFR TKIs in EGFR mutant NSCLC patients (pts).The highly selective c-Met inhibitor tepotinib (MSC2156...
Activity of the c-Met inhibitor tepotinib (MSC2156119J) in combination with gefitinib in Asian patie
[会议论文] 作者：Yi-long Wu,Keunchil Park,Dong-wan Kim,Ross a.Soo,Cindy Li,Huiling Xiong,Christian Ihling,James chih-hsin,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: c-Met abnormalities can cause resistance to EGFR TKIs in EGFR mutant NSCLC patients (pts).The highly selective c-Met inhibitor tepotinib (MSC2156119J) had promising activity in a phase Ⅰ tr...
Safety and efficacy of the Asian subgroup of patients (pts) with EGFR-TKI-resistant advanced non-sma
[会议论文] 作者：Myung-Ju Ahn,Yuichiro Ohe,James Chih-Hsin Yang,Dong-Wan Kim,Sang-We Kim,Yuri Rukazenkov,Mireille Cantarini,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
...
Safety and efficacy of the Asian subgroup of patients (pts) with EGFR-TKI-resistant advanced non-sma
[会议论文] 作者：Myung-Ju Ahn,Yuichiro Ohe,James Chih-Hsin Yang,Dong-Wan Kim,Sang-We Kim,Yuri Rukazenkov,Mireille Cantarini,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
Objective: AZD9291 is an oral, potent, irreversible EGFR-TKI, selective for sensitizing (EGFRm+) and T790M resistance mutations, currently under investigation in an ongoing Phase Ⅰ study of pts with E...
Pembrolizumab (MK-3475) in patients (pts) with extensive-stage small cell lung cancer (SCLC): Prelim
[会议论文] 作者：Patrick Alexander Ott,Maria Elena Elez Fernandez,Sandrine Hiret,Dong-Wan Kim,Rebecca Anne Moss,Tammy,
来源：2015年临床肿瘤学新进展学术研讨会 年份：2015
...
[期刊论文] 作者：Jaeyoung Cho,Sun Mi Choi,Jinwoo Lee,Chang-Hoon Lee,Sang-Min Lee,Dong-Wan Kim,Jae-Joon Yim,Young Tae Kim,
来源：Chinese Journal of Cancer 年份：2017
Background: The proportion of never?smokers with non?small cell lung cancer(NSCLC) is increasing, but that in Korea has not been well addressed in a large popul...
[会议论文] 作者：Sai-hong Ou,Alice Shaw,Ramaswamy Govindan,Mark Socinski,Ross Camidge,Luigi De Petris,Dong-wan Kim,Alberto,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: The central nervous system (CNS) is a frequent site of progression in ALK+ NSCLC patients treated with crizotinib, thus good CNS efficacy is of crucial importance for new ALK inhibitors....
[期刊论文] 作者：显示全部作者", class=",showAll",>,,Dong-Wan KIM,Silvia NOVELLO,Miyako SATOUCHI,Yi-Long WU,Edward,
来源：中国肺癌杂志 年份：2022
背景与目的 我们回顾性评估了程序性死亡配体1（programmed death ligand 1, PD-L1）阳性非小细胞肺癌（non-small cell lung cancer, NSCLC）患者的预后，以比较基线（即入组时）脑转移与帕博利珠单抗及化疗的疗效关系。方法 我们汇总分析了KEYNOTE-001（NCT01295827）、KEYNOTE-......
[期刊论文] 作者：Kwon,Chan-Young Ock,Miso Kim,Tae Min Kim,Hak Jae Kim,Yoon Kyung Jeon,In Kyu Park,Chang Hyun Kang,Dong-Wan Kim,
来源：World Journal of Gastroenterology 年份：2016
AIM To investigate the expression and prognostic role of programmed death ligand-1(PD-L1) in locally advanced esophageal squamous cell carcinoma(ESCC).METHODS A...
相关搜索：
